A · Agilent Technologies, Inc.

This executive change reflects a planned leadership transition in Agilent’s legal function, a critical area given the company’s global regulatory exposure, active M&A history, and clinical/analytical instrumentation business model. Buckner’s background — including senior legal roles at Danaher and GE, with deep expertise in M&A, antitrust, IP transactions, and board-level risk advisory — directly aligns with Agilent’s strategic priorities, particularly its ongoing portfolio optimization and international compliance demands. His appointment follows DiMarco’s pre-announced departure under a structured transition agreement, minimizing operational disruption. While the role is not part of the CEO or CFO office, the Chief Legal Officer oversees governance, regulatory strategy, litigation, and transactional execution — all material to investor assessments of legal risk, deal execution capability, and ESG-related oversight. The fact that DiMarco remains engaged through December 1, 2026, as Special Advisor further mitigates near-term knowledge transfer risk. No compensation terms for either officer are disclosed in the filing.